Skip to content
StockMarketAgent
Direct answer
BRK.B trades against a final fair-value range of $374.65-$742.60, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $375, high $743, with mid-point at $550.
Stock analysis

BRK.B Berkshire Hathaway Inc. Class B fair value $550–$743

BRK.B
By StockMarketAgent.AI team· supervised by
Analyzed: 2026-05-08Next update: 2026-08-08Methodology v2.4Archetype: FinancialNYSE · Financials
View archive
Last price
$475.08
▲ +74.67 (+15.72%)
Fair value
$550
$550–$743
Rating
Buy
confidence 65/100
Upside
+15.7%
upside to fair value
Margin of Safety
$467.29
buy below · 15%
Market Cap
$1.02T
P/E fwd 22.4

§1 Executive summary

  • Composite fair value $550 with high case $743.
  • Implied upside of 15.7% to fair value.
  • Moat 9/10 · confidence 65/100 · Financial.
  • Trades at a measured discount to fair value with adequate margin of safety.
Fair value
$550
Margin of safety
+13.6%
Confidence
65/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$475.08Price
FV $549.75
High $742.6

BRK.B trades against a final fair-value range of $374.65-$742.60, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Zero-cost insurance float (~$170B+) functions
    Zero-cost insurance float (~$170B+) functions as permanent, non-callable leverage — no competitor replicates this at scale
  • BNSF and BHE operate as
    BNSF and BHE operate as regulated/quasi-monopoly infrastructure with pricing power indexed to inflation
  • Cycle upside
    Hard insurance market extends through 2027, driving premium growth of 8-12% and combined ratios below 95%. Rising interest rates boost float income. BHE rate cases approved, improving utility ROE toward allowed returns.

§2 Bear case

Under a combined stress scenario — recession reducing underwriting profits by 40%, equity portfolio declining 30%, and BNSF volumes falling 15% — operating earnings could compress to ~$25B from ~$40B normalized. At 10x stressed earnings plus $300B cash at par, trough equity value approximates $400/share (0.95x book). The cash fortress prevents permanent impairment but does not prevent a 15-20% drawdown.

Ways this thesis can break

Succession-driven capital allocation deterioration

25-35% over 5 years· Medium

Greg Abel lacks Buffett's investment track record. A single large misallocation ($50B+ acquisition at inflated multiples) could permanently impair book value growth trajectory and trigger conglomerate discount widening from 1.4x to sub-1.0x P/B.

FV impact
−30% to −40% ($290-$330/share)
Trigger
2026-2030

PacifiCorp wildfire liability crystallization

15-20%· Low

BHE subsidiary PacifiCorp faces multi-billion dollar wildfire claims in Oregon. If total liabilities exceed $15B (vs current reserves), BHE equity could be impaired, requiring Berkshire parent capital injection and reducing consolidated book value.

FV impact
−8% to −12% ($420-$450/share)
Trigger
2026-2028

Forced Apple divestiture or mark-to-market tax event

10-15%· Low

Regulatory or tax-policy changes force liquidation of the ~$70B Apple position, crystallizing $50B+ in embedded capital gains taxes and permanently reducing the equity portfolio's compounding capacity.

FV impact
−10% to −15% ($400-$430/share)
Trigger
2027-2030
Early-warning signals to monitor
MetricCurrentTrigger threshold
Combined ratio sustained above 100% for two consecutive quartersMonitorDeterioration versus the report thesis
Book value per share growth decelerating below 5% annualizedMonitorDeterioration versus the report thesis
Cash deployment into acquisitions above 2x trailing book value of targetMonitorDeterioration versus the report thesis
BNSF operating ratio exceeding 70% (currently ~60%)MonitorDeterioration versus the report thesis
Greg Abel increasing centralization or departing from decentralized operating philosophyMonitorDeterioration versus the report thesis

§3 Financial history

Income statement — last six periods
Line itemT−0T−1T−2T−3T−4CAGR
Period2021-12-312022-12-312023-12-312024-12-312025-12-31Trend
Revenue$276.19B$302.02B$364.48B$371.43B$371.44B+7.7%
Gross profit
Operating income
Net income$89.94B$-22.76B$96.22B$89.00B$66.97B-7.1%
EPS (diluted)
EBITDA
R&D
SG&A

Quality scores

Piotroski F-score
2 / 9
0–9 quality composite
OCF / Net income
0.69×
>1 indicates high earnings quality
Accounting quality gate
Fail
Sector-adjusted gate
ROIC
Return on invested capital
§3

Numbers analysis

Cash flow

Cash-flow quality is reflected in the OCF / net income, accounting-quality, and ROIC rows above.

Capital allocation

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Individual subscribers — §4 onwards11 more sections

Read the full analysis — 11 more sections.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Full report for every covered ticker
24 months of rating archive
Watchlist briefings + rating-change alerts
PDF + DOCX export in any language
Start free trial
Cancel anytime.
FAQ

BRK.B — frequently asked questions

  1. Based on our latest independent analysis, BRK.B looks meaningfully undervalued. The current price is $475 versus a composite fair-value midpoint of $550 (range $375–$743), which implies roughly 15.7% upside to the midpoint.